| Literature DB >> 21227764 |
Chehrazade Brick1, Ouafa Atouf, Nadia Benseffaj, Malika Essakalli.
Abstract
Rejection occurs after the introduction of a genetically different graft, in a recipient. Nowadays, it is still a major obstacle in renal transplantation and reflects a normal protective immune response of a recipient against a foreign antigen. Involving many mechanisms of the innate and adaptive immunity, this reaction results in renal parenchymal lesions witch may progress to graft destruction and loss of its function. Several ways are currently used to reduce the action of the immune system and consequently reduce the risk of rejection. After a presentation of the main actors and the sequence of events leading to rejection, we will describe the strategy used by antirejection teams' transplantation. We will successively consider the prevention (pre-transplant immunological assessment, preventive immunosuppressive therapy), the monitoring (search for antibodies, biopsies) and the treatment.Entities:
Mesh:
Year: 2011 PMID: 21227764 DOI: 10.1016/j.nephro.2010.10.002
Source DB: PubMed Journal: Nephrol Ther ISSN: 1769-7255 Impact factor: 0.722